Tin tức & Cập nhật
Lọc theo Chuyên ngành:

Healthy eating may hold back prostate cancer progression
Sticking to a diet that follows the American dietary guideline recommendations may forestall the potential for low-grade prostate cancer to progress to high-grade disease, as suggested in a study.
Healthy eating may hold back prostate cancer progression
26 Oct 2024
DISCREET highlights apremilast potential for genital psoriasis
Individuals with psoriasis creeping into their intimate areas may find relief from apremilast, as shown by the week-32 improvements in multiple disease parameters in the phase III DISCREET study.
DISCREET highlights apremilast potential for genital psoriasis
22 Oct 2024
Metastatic prostate cancer risk low in older men nearing age limit for PSA screening
Older men who have had prostate-specific antigen (PSA) testing and are approaching the age limit for recommended screening appear to have a relatively low risk of developing metastatic or fatal prostate cancer, suggests a recent study.
Metastatic prostate cancer risk low in older men nearing age limit for PSA screening
16 Oct 2024
NIAGARA interim data support perioperative durvalumab for MIBC
In a preplanned interim analysis of the NIAGARA trial, the addition of durvalumab to neoadjuvant chemotherapy prior to radical cystectomy (RC) and durvalumab monotherapy following surgery confers a survival advantage over chemo alone for muscle-invasive bladder cancer (MIBC).
NIAGARA interim data support perioperative durvalumab for MIBC
10 Oct 2024
Darolutamide + ADT, without docetaxel, shows efficacy benefits in mHSPC
Darolutamide plus androgen-deprivation therapy (ADT), without docetaxel, improves radiological progression-free survival (rPFS) and secondary efficacy outcomes vs placebo plus ADT in patients with metastatic hormone-sensitive prostate cancer (mHSPC), according to results of the global phase III ARANOTE trial presented at ESMO 2024.